AU5746400A - 1-(4-arylsulfonyl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 - Google Patents

1-(4-arylsulfonyl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2

Info

Publication number
AU5746400A
AU5746400A AU57464/00A AU5746400A AU5746400A AU 5746400 A AU5746400 A AU 5746400A AU 57464/00 A AU57464/00 A AU 57464/00A AU 5746400 A AU5746400 A AU 5746400A AU 5746400 A AU5746400 A AU 5746400A
Authority
AU
Australia
Prior art keywords
pyrazolines
cyclooxygenase
arylsulfonyl
inhibitors
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57464/00A
Inventor
E. Premkumar Reddy
M. V. Ramana Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple University of Commonwealth System of Higher Education
Original Assignee
Temple University of Commonwealth System of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple University of Commonwealth System of Higher Education filed Critical Temple University of Commonwealth System of Higher Education
Publication of AU5746400A publication Critical patent/AU5746400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU57464/00A 1999-06-16 2000-06-16 1-(4-arylsulfonyl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 Abandoned AU5746400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13941499P 1999-06-16 1999-06-16
US60139414 1999-06-16
PCT/US2000/016727 WO2000076983A1 (en) 1999-06-16 2000-06-16 1-(4-arylsulfonyl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2

Publications (1)

Publication Number Publication Date
AU5746400A true AU5746400A (en) 2001-01-02

Family

ID=22486532

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57464/00A Abandoned AU5746400A (en) 1999-06-16 2000-06-16 1-(4-arylsulfonyl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2

Country Status (2)

Country Link
AU (1) AU5746400A (en)
WO (1) WO2000076983A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE448207T1 (en) 2002-03-08 2009-11-15 Merck & Co Inc MITOTIC KINESIN INHIBITORS
US20100105729A1 (en) * 2006-10-06 2010-04-29 Kalypsys, Inc. Aryl-substituted heterocyclic pde4 inhibitors as anti-inflammatory agents

Also Published As

Publication number Publication date
WO2000076983A1 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
AU2002331311A1 (en) Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
AU2001228309A1 (en) N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
AU2002305205A1 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
AU2001244399A1 (en) Gamma-secretase inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU6762400A (en) Inhibitors of factor xa
AU5723500A (en) Inhibitors of factor xa
AU2002234047A1 (en) Pyrazole compounds useful as protein kinase inhibitors
AU2002231166A1 (en) Pyrazole compounds useful as protein kinase inhibitors
AU5283700A (en) Inhibitors of factor xa
AU5155500A (en) Inhibitors of factor xa
AU3857300A (en) Inhibitors of factor xa
HK1041407B (en) Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
AU6111000A (en) Inhibitors of viral helcase
AU5283600A (en) Inhibitors of factor xa
AU2003238042A1 (en) Cyclooxygenase-2 inhibitors
AU2001265182A1 (en) Inhibitors of matrix metalloproteinases
AU3512400A (en) Novel post-amadori inhibitors of advanced glycation reactions
AU7961300A (en) Kainic acid neurocytotoxicity inhibitors
AU7125700A (en) Enzyme inhibitors
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU3235100A (en) Prothease inhibitors
AU7957000A (en) Cyclooxygenase-2 expression inhibitors
AU2002214038A1 (en) Inhibitors of transglutaminases
AU2252101A (en) New synthesis of SPLA2 inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase